Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.86 USD | -1.59% | -6.53% | -17.33% |
Mar. 29 | TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 06 | Knight Therapeutics Announces Launch of Bijuva in Canada | MT |
Financials (USD)
Sales 2022 | 69.96M | Sales 2023 | 1.3M | Capitalization | 25.77M |
---|---|---|---|---|---|
Net income 2022 | 112M | Net income 2023 | -10M | EV / Sales 2022 | 0.34 x |
Net cash position 2022 | 29.31M | Net Debt 2023 | 3.68M | EV / Sales 2023 | 22.6 x |
P/E ratio 2022 |
0.47
x | P/E ratio 2023 |
-2.28
x | Employees | 1 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.22% |
1 day | -1.59% | ||
1 week | -6.53% | ||
Current month | -18.78% | ||
1 month | -18.78% | ||
3 months | -16.63% | ||
6 months | -20.85% | ||
Current year | -17.33% |
Managers | Title | Age | Since |
---|---|---|---|
Marlan Walker
CEO | Chief Executive Officer | 50 | 13-05-31 |
Joseph Ziegler
DFI | Director of Finance/CFO | - | 23-08-16 |
Corporate Officer/Principal | - | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tommy Thompson
CHM | Chairman | 81 | 12-04-15 |
Cooper Collins
BRD | Director/Board Member | 45 | 12-02-27 |
Gail Naughton
BRD | Director/Board Member | 69 | 20-03-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 1.89 | 0.00% | 5,739 |
24-04-17 | 1.89 | -0.53% | 29,032 |
24-04-16 | 1.9 | -2.56% | 45,679 |
24-04-15 | 1.95 | -2.01% | 38,139 |
24-04-12 | 1.99 | -4.33% | 32,038 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-17.33% | 21.8M | |
+10.08% | 9.12B | |
-17.63% | 4.8B | |
+0.73% | 3.8B | |
+16.55% | 3.72B | |
+27.76% | 2.58B | |
-26.11% | 2.36B | |
-30.09% | 2.11B | |
+7.15% | 1.86B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- TXMD Stock